Intermittent androgen suppression

被引：16
作者：
Pether, M [1 ]
Goldenberg, SL [1 ]
机构：
[1] Univ British Columbia, Dept Surg, Div Urol, VGH,Prostate Ctr, Vancouver, BC V6T 1W5, Canada
来源：
BJU INTERNATIONAL | 2004年 / 93卷 / 03期
关键词：
prostate cancer; androgens; intermittent therapy; outcome; survival;
D O I：
10.1111/j.1464-410X.2004.04597.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 261
页数：4
相关论文
共 36 条
[1]  
Adib RS, 1997, BRIT J UROL, V79, P235
[2]  
AKAKURA K, 1993, CANCER, V71, P2782, DOI 10.1002/1097-0142(19930501)71:9<2782::AID-CNCR2820710916>3.0.CO
[3]  
2-Z
[4]   Intermittent androgen suppression in the treatment of metastatic prostate cancer [J].
Bouchot, O ;
Lenormand, L ;
Karam, G ;
Prunet, D ;
Gaschignard, N ;
Malinovsky, JM ;
Buzelin, JM .
EUROPEAN UROLOGY, 2000, 38 (05) :543-549
[5]  
BRUCHOVSKY N, 1990, CANCER RES, V50, P2275
[6]  
BRUCHOVSKY N, 1995, UROLOGE A, V34, P389
[7]  
BRUCHOVSKY N, 1996, CANC MED, P1133
[8]   Intermittent androgen suppression in the management of prostate cancer [J].
Crook, JM ;
Szumacher, E ;
Malone, S ;
Huan, S ;
Segal, R .
UROLOGY, 1999, 53 (03) :530-534
[9]   Osteoporosis after orchiectomy for prostate cancer [J].
Daniell, HW .
JOURNAL OF UROLOGY, 1997, 157 (02) :439-444
[10]  
DENIS L, 1993, CANCER, V72, P3888, DOI 10.1002/1097-0142(19931215)72:12+<3888::AID-CNCR2820721726>3.0.CO
1234